A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to identify the best dose of V81444 to use in future trials
in patients with Parkinson's disease. The study will also explore the effects of V81444 on
brain activity and blood flow with tests of mental ability ("cognitive function tests"). It
will also check how safe V81444 is and how well it is tolerated after dosing.